GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (LTS:0H22) » Definitions » Cyclically Adjusted Book per Share

BioInvent International AB (LTS:0H22) Cyclically Adjusted Book per Share : kr18.07 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is BioInvent International AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BioInvent International AB's adjusted book value per share for the three months ended in Mar. 2025 was kr11.697. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr18.07 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BioInvent International AB's average Cyclically Adjusted Book Growth Rate was -0.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BioInvent International AB was 7.80% per year. The lowest was -17.10% per year. And the median was -7.30% per year.

As of today (2025-05-25), BioInvent International AB's current stock price is kr33.10. BioInvent International AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr18.07. BioInvent International AB's Cyclically Adjusted PB Ratio of today is 1.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioInvent International AB was 3.58. The lowest was 0.83. And the median was 1.92.


BioInvent International AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for BioInvent International AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInvent International AB Cyclically Adjusted Book per Share Chart

BioInvent International AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.78 14.06 17.82 17.39 18.12

BioInvent International AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.91 18.39 18.03 18.12 18.07

Competitive Comparison of BioInvent International AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, BioInvent International AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioInvent International AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioInvent International AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioInvent International AB's Cyclically Adjusted PB Ratio falls into.


;
;

BioInvent International AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioInvent International AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=11.697/132.8245*132.8245
=11.697

Current CPI (Mar. 2025) = 132.8245.

BioInvent International AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 10.176 99.995 13.517
201509 7.030 100.228 9.316
201512 4.101 100.276 5.432
201603 4.472 100.751 5.896
201606 18.428 101.019 24.230
201609 15.958 101.138 20.958
201612 18.525 102.022 24.118
201703 16.728 102.022 21.779
201706 14.840 102.752 19.183
201709 13.135 103.279 16.893
201712 10.469 103.793 13.397
201803 12.979 103.962 16.582
201806 9.953 104.875 12.606
201809 8.404 105.679 10.563
201812 6.118 105.912 7.673
201903 5.971 105.886 7.490
201906 12.106 106.742 15.064
201909 10.302 107.214 12.763
201912 8.294 107.766 10.223
202003 6.680 106.563 8.326
202006 8.139 107.498 10.057
202009 17.115 107.635 21.120
202012 18.882 108.296 23.159
202103 26.769 108.360 32.813
202106 25.793 108.928 31.452
202109 24.722 110.338 29.760
202112 23.379 112.486 27.606
202203 22.221 114.825 25.704
202206 25.096 118.384 28.157
202209 25.924 122.296 28.156
202212 24.722 126.365 25.986
202303 23.765 127.042 24.847
202306 22.435 129.407 23.028
202309 21.371 130.224 21.798
202312 19.903 131.912 20.041
202403 18.732 132.205 18.820
202406 16.679 132.716 16.693
202409 15.244 132.304 15.304
202412 13.461 132.987 13.445
202503 11.697 132.825 11.697

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


BioInvent International AB  (LTS:0H22) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioInvent International AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=33.10/18.07
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioInvent International AB was 3.58. The lowest was 0.83. And the median was 1.92.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BioInvent International AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of BioInvent International AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioInvent International AB Business Description

Traded in Other Exchanges
Address
Ideongatan 1, Lund, SWE, SE-223 70
BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

BioInvent International AB Headlines

No Headlines